Managing aggression in psychiatric patients with a care bundle approach
Effect of Using Care Bundle in the Aggression Management of Patients With Psychotic Disorders
This study is testing a new approach to manage aggression in patients with psychotic disorders to see if it works better than the usual care they receive.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Male |
| Sponsor | Abant Izzet Baysal University Academic / other |
| Locations | 1 site (Bolu, Bolu Province) |
| Trial ID | NCT06661824 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and evaluate an aggression management care bundle specifically designed for patients with psychotic disorders in a psychiatric clinic. It employs a sequential randomized controlled experimental design to test the effectiveness of this care bundle in reducing aggressive behaviors compared to routine care. The study will assess the frequency of aggressive events, the use of restrictive management techniques, and the compliance rate of the care bundle among healthcare professionals. By focusing on evidence-based interventions, the study seeks to improve patient outcomes and enhance safety in psychiatric settings.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-65 who have been newly admitted to a psychiatric clinic with a diagnosis of schizophrenia or psychosis and exhibit signs of potential aggression.
Not a fit: Patients who are unable to provide informed consent or are first-time admissions to a psychiatric clinic may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce aggressive incidents in psychiatric wards, improving safety for both patients and healthcare providers.
How similar studies have performed: While there have been various approaches to managing aggression in psychiatric settings, the specific care bundle method being tested in this study is relatively novel and has not been widely implemented.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between 18-65 years of age, * Being able to speak and understand Turkish, * Having one of the disorders within the scope of Schizophrenia and psychosis, * Being newly admitted to Bolu İzzet Baysal Mental Health and Diseases Hospital during the period the research was conducted, * Having scored 1 point or more on the Broset Violence Checklist or 65 points or more on the Buss-Perry Aggression Questionnaire. Exclusion Criteria: * Not being able to give written informed consent, * Being the first time a patient has been admitted to a psychiatric clinic, * Having developmental delay or any other significant organic brain pathology.
Where this trial is running
Bolu, Bolu Province
- Bolu Mental Health and Diseases Hospital — Bolu, Bolu Province, Turkey (Recruiting)
Study contacts
- Principal investigator: Melisa Bulut, RN, PhD cand — Bolu Abant İzzet Baysal University
- Study coordinator: Melisa Bulut, RN, PhD cand
- Email: melisa.bulut@ibu.edu.tr
- Phone: +905348855882
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.